Concentrated Omega-3 Oils Gain in Pharmaceutical and Premium Nutrition Uses
Drug makers and premium supplement brands buy concentrated, purified fish oil with 50% to 90% EPA and DHA, and refiners add molecular distillation and enzymatic concentration to serve them. Refined Omega-3 Concentrate Oil grows about 8.4% a year, and gross margins run 30% to 42% against 12% to 20% for aquafeed oil. The trend needs refining capacity, quality systems, and regulatory approvals. Supply contracts decide renewal. Delivery reliability decides supplier rankings. Margins follow refining discipline. Batch records protect future sales. Cost control separates leaders from followers. Clear specifications build buyer trust. Small refiners feel every raw material swing.
Market Impact: aquaculture output grows 4% yearly








